IRIDEX (IRIX) CFO buys 1,300 shares of common stock at $1.46

Rhea-AI Filing Summary

IRIDEX Corporation’s Chief Financial Officer, Romeo R. Dizon, reported an open-market purchase of company stock. On January 28, 2026, he bought 1,300 shares of common stock at $1.46 per share. Following this transaction, he directly owns 111,589 shares of IRIDEX common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CA 94043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/28/2026		P		1,300	A	$1.46	111,589	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	01/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IRIDEX (IRIX) report in this Form 4?

IRIDEX reported that its Chief Financial Officer, Romeo R. Dizon, purchased 1,300 shares of common stock. The transaction occurred on January 28, 2026 at a price of $1.46 per share, indicating an open-market buy of IRIDEX stock.

How many IRIDEX (IRIX) shares did the CFO buy and at what price?

The IRIDEX Chief Financial Officer purchased 1,300 shares of common stock at $1.46 per share. This open-market transaction increased his direct holdings and reflects the price he paid for each IRIDEX share on January 28, 2026.

What is Romeo R. Dizon’s total IRIDEX (IRIX) share ownership after the trade?

After the reported transaction, Romeo R. Dizon directly owns 111,589 shares of IRIDEX common stock. This figure represents his beneficial ownership immediately following the January 28, 2026 purchase of 1,300 additional IRIDEX shares at $1.46 each.

Was the IRIDEX (IRIX) CFO’s Form 4 transaction a purchase or a sale?

The Form 4 shows a purchase of IRIDEX common stock by the Chief Financial Officer. The transaction code is “P,” indicating an open-market or private purchase of 1,300 shares at a price of $1.46 per share on January 28, 2026.

Does the IRIDEX (IRIX) Form 4 indicate direct or indirect ownership?

The filing reports the CFO’s holdings as direct ownership, marked with a “D” in the ownership column. Following the January 28, 2026 purchase, he directly holds 111,589 IRIDEX common shares, with no additional nature of indirect beneficial ownership disclosed.

Who signed the IRIDEX (IRIX) Form 4 for the CFO’s transaction?

The Form 4 was signed by Nilo De Castro as attorney-in-fact for Romeo R. Dizon. The signature is dated January 28, 2026, documenting the reporting of the CFO’s purchase of 1,300 IRIDEX common shares at $1.46 per share.